Literature DB >> 11226980

Metabolic syndrome and ischemic heart disease in elderly men and women.

U Lindblad1, R D Langer, D L Wingard, R G Thomas, E L Barrett-Connor.   

Abstract

Associations between metabolic syndrome components and prevalent ischemic heart disease (IHD) were investigated in a cross-sectional, community-based study of elderly men (n = 1,015) and women (n = 1,259) in Rancho Bernardo, California, in 1984-1987. In both sexes, there were significant positive associations between IHD defined by resting electrocardiogram criteria and age, systolic blood pressure, fasting and postchallenge hyperglycemia, total cholesterol/high density lipoprotein cholesterol (HDL cholesterol) ratio, and triglycerides and an inverse significant association with HDL cholesterol. High collinearity and interactions between serum insulin and metabolic syndrome variables were accounted for by uncorrelated principal components identified by factor analysis. In both men and women, three uncorrelated principal components were identified, representing a central metabolic factor (body mass index, fasting and 2-hour serum insulin, high serum triglycerides, and low HDL cholesterol), a glucose factor, and a blood pressure factor. In a multivariate model with age and sex, all three factors were significantly associated with IHD by electrocardiogram criteria; central metabolic factor (odds ratio (OR) = 1.6, p = 0.001), glucose factor (OR = 1.4, p < 0.001), blood pressure factor (OR = 1.2, p = 0.005), age (10 years) (OR = 1.8, p < 0.001), and female sex (OR = 0.5, p < 0.02). Similar results were obtained in analyses using clinically manifest IHD as the outcome. These results support the thesis that the metabolic syndrome exerts effects through different risk factors by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226980     DOI: 10.1093/aje/153.5.481

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

2.  Executive functioning and the metabolic syndrome: a project FRONTIER study.

Authors:  Jed Falkowski; Timothy Atchison; Maxine Debutte-Smith; Myron F Weiner; Sid O'Bryant
Journal:  Arch Clin Neuropsychol       Date:  2013-10-22       Impact factor: 2.813

3.  Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.

Authors:  Paul Holvoet; Duk-Hee Lee; Michael Steffes; Myron Gross; David R Jacobs
Journal:  JAMA       Date:  2008-05-21       Impact factor: 56.272

4.  Stability of the factor structure of the metabolic syndrome across pubertal development: confirmatory factor analyses of three alternative models.

Authors:  Elizabeth Goodman; Chaoyang Li; Yu-Kang Tu; Earl Ford; Shumei S Sun; Terry T-K Huang
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

5.  ELECTROCARDIOGRAPHIC ABNORMALITIES AMONG MEXICAN AMERICANS: CORRELATIONS WITH DIABETES, OBESITY, AND THE METABOLIC SYNDROME.

Authors:  Saulette R Queen; Beverly Smulevitz; Anne R Rentfro; Kristina P Vatcheva; Hyunggun Kim; David D McPherson; Craig L Hanis; Susan P Fisher-Hoch; Joseph B McCormick; Susan T Laing
Journal:  World J Cardiovasc Dis       Date:  2012-04

6.  An evaluation of the metabolic syndrome in the HyperGEN study.

Authors:  Aldi T Kraja; Steven C Hunt; James S Pankow; Richard H Myers; Gerardo Heiss; Cora E Lewis; Dc Rao; Michael A Province
Journal:  Nutr Metab (Lond)       Date:  2005-01-18       Impact factor: 4.169

7.  Asthma and high-intensity interval training have no effect on clustered cardiometabolic risk or arterial stiffness in adolescents.

Authors:  M A McNarry; L Lester; E A Ellins; J P Halcox; G Davies; C O N Winn; K A Mackintosh
Journal:  Eur J Appl Physiol       Date:  2021-03-29       Impact factor: 3.078

8.  Factor structure underlying components of allostatic load.

Authors:  Jeanne M McCaffery; Anna L Marsland; Kelley Strohacker; Matthew F Muldoon; Stephen B Manuck
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.